Emergent BioSolutions
EBS
#8033
Rank
$0.37 B
Marketcap
$7.22
Share price
-0.55%
Change (1 day)
18.95%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): $59.1 Million USD

According to Emergent BioSolutions 's latest financial reports the company's current earnings are $0.64 Billion USD. In 2025 the company made an earning of $0.14 Billion USD, an increase over its 2024 earnings that were of -$71.9 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $59.1 M-58.41%
2025 $0.14 B-297.64%
2024 -$71.9 Million-88.82%
2023 -$0.65 Billion242.73%
2022 -$0.19 Billion-153.8%
2021 $0.34 B-20.43%
2020 $0.43 B278.02%
2019 $0.11 B27.11%
2018 $91.25 M-27.12%
2017 $0.12 B17.21%
2016 $0.10 B0.45%
2015 $0.10 B73.51%
2014 $61.3 M41.36%
2013 $43.36 M35.2%
2012 $32.07 M0.4%
2011 $31.94 M-56.46%
2010 $73.37 M76.73%
2009 $41.51 M32.94%
2008 $31.23 M-5.62%
2007 $33.09 M
2005 $47.91 M269.89%
2004 $12.95 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$13.15 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$10.01 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-$11.71 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
$20.63 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.31 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.27 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel